NCR2 and central nervous system cancer: Additionally, the pNK cells showed a significant increase in NKp44-activating receptor expression, which might induce a high efficacy against cancers with a high expression of NKp44 ligand, MML5, or PDGF, such as glioma, gastro-intestinal stromal tumor, and triple-negative breast cancer [35].